Improvement of oral bioavailability of flurbiprofen from flurbiprofen/β-cyclodextrin inclusion complex by action of cinnarizine

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 73, Issue 1, 2009, Pages 202-204

  Tokumura, Tadakazu ^a   Muraoka, Atsushi ^a   Machida, Yoshiharu ^a  

^a HOSHI UNIVERSITY   (Japan)

Author keywords

Cyclodextrin; Bioavailability; Cinnarizine; Competing agent; Flurbiprofen; Inclusion complex; Rats

Indexed keywords

BETA CYCLODEXTRIN; CINNARIZINE; FLURBIPROFEN;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG POTENTIATION; DRUG SOLUBILITY; MALE; MAXIMUM PLASMA CONCENTRATION; MEAN RESIDENCE TIME; NONHUMAN; PLASMA CONCENTRATION-TIME CURVE; RAT; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ANIMALS; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CINNARIZINE; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; DRUG INTERACTIONS; FLURBIPROFEN; MALE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 68349152797     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2009.04.018     Document Type: Article

References (10)

1. Fukuhara A., Imai T., Inoue K., and Otagiri M. Effect of oral multiple-dose administration of anti-inflammatory flurbiprofen chimera drug on gastric lesion, other toxicities and disposition kinetics. Biol. Pharm. Bull. 18 (1995) 140-147
2. Otagiri M., Imai T., Matumoto N., and Uekama K. Improvements to some pharmaceutical properties of flurbiprofen by β- and γ-cyclodextrin complexations. Acta Pharm. Suec. 20 (1983) 1-10
3. Otagiri M., Imai T., Hirayama F., Uekama K., and Yamasaki M. Inclusion complex formations of the anti-inflammatory drug flurbiprofen with cyclodextrins in aqueous solution and in solid state. Acta Pharm. Suec. 20 (1983) 11-20
4. Tokumura T., Muraoka A., and Machida Y. A simple determination method for flurbiprofen by high-performance liquid chromatography and its pharmacokinetics on intravenous administration in rats. STP Pharma Sci. 13 (2003) 415-418
5. Muraoka A., Tokumura T., and Machida Y. Evaluation of the bioavailability of flurbiprofen and its β-cyclodextrin inclusion complex in four different doses upon oral administration to rats. Eur. J. Pharm. Biopharm. 58 (2004) 607-671
6. Tokumura T., Ueda H., Tsushima Y., Kasai M., Kayano M., Amada I., and Nagai T. Inclusion complexes of cinnarizine with β-cyclodextrin in aqueous solution and in the solid state. Chem. Pharm. Bull. 32 (1984) 4179-4184
7. Muraoka A., Tokumura T., and Machida Y. In vitro evaluation of cinnarizine as a competing agent to β-cyclodextrin inclusion complexes: effect of cinnarizine on the membrane permeation rate of progesterone from its β-cyclodextrin inclusion complex. Yakugaku Zasshi 128 (2008) 89-95
8. Tokumura T., Nanba M., Tsushima Y., Tatsuishi K., Kayano M., Machida Y., and Nagai T. Enhancement of bioavailability of cinnarizine from its β-cyclodextrin complex on oral administration with dl-phenylalanine as a competing agent. J. Pharm. Sci. 75 (1986) 391-394
9. Uekama K. Pharmaceutical application of cyclodextrin complexation. Yakugaku Zasshi 101 (1981) 857-873
10. Machida R., Tokumura T., Tsuchiya Y., Sasaki A., and Abe K. Pharmacokinetics of novel hexapeptides with neurotensin activity in rats. Biol. Pharm. Bull. 16 (1993) 43-47